This is a routine resale registration and not a new capital raise. Traders should note that the resale of these shares could increase market supply and potentially pressure the stock price, especially from large holders like Dr. Reddy's and Greenlight Capital. Monitor for any significant selling activity by these holders.
Price Chart
Executive Summary
Coya Therapeutics filed an S-3 shelf registration to register 2,522,727 shares of common stock for resale by selling stockholders, including Greenlight Capital and Dr. Reddy's Laboratories, who acquired the shares in a private placement at $4.40 per share. The company will not receive any proceeds from the resale of these shares, which were issued in January 2026. This filing is a routine registration to facilitate the resale of privately placed shares and does not represent a new capital raise by the company.
Key Facts
- Coya Therapeutics filed an S-3 registration statement to register 2,522,727 shares of common stock for resale by selling stockholders.
- The shares were issued in a private placement on January 29, 2026, at $4.40 per share.
- The company will not receive any proceeds from the resale of these shares.
- Selling stockholders include Greenlight Capital (250,000 shares) and Dr. Reddy's Laboratories (2,272,727 shares).
- The registration is required under the terms of the private placement agreement to allow the investors to freely trade their shares.
Financial Impact
No financial impact to the company as it will not receive any proceeds from the resale.
Risk Factors
- Potential for increased selling pressure from the registered shares being sold in the market.
- No proceeds to the company means no additional capital for operations or R&D.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-107413 |
| Document: d206837dexfilingfees.htm | 0001193125-26-107413 |
| Document: d206837dex51.htm | 0001193125-26-107413 |
| Document: d206837dex231.htm | 0001193125-26-107413 |
| Document: 0001193125-26-107413-index-headers.html | 0001193125-26-107413 |
| Document: 0001193125-26-107413-index.html | 0001193125-26-107413 |
| Document: 0001193125-26-107413.txt | 0001193125-26-107413 |
| CONTEXT: 10-Q (2025-11-12) | 0001193125-25-276058 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $4.18 | awaiting T+20 | — | $4.17 (−0.24%) |
Oct 5, 2026 22d ago | 8-K | $4.85 | awaiting T+20 | — | $4.17 (−14.02%) |
Sep 15, 2026 6w ago | 8-K | $4.65 $4.48 | ▼ −3.76% | ▼ −6.74% | $4.17 (−10.32%) |
Aug 11, 2026 11w ago | 8-K | $4.80 $4.61 | ▼ −3.96% | ▼ −2.90% | $4.17 (−13.12%) |
May 12, 2026 24w ago | 8-K | $4.29 $4.41 | ▲ +2.80% | ▲ +4.52% | $4.17 (−2.80%) |
Apr 2, 2026 29w ago | 8-K | $4.01 $4.23 | ▲ +5.49% | ▼ −4.39% | $4.17 (+3.99%) |
Mar 23, 2026 31w ago | EFFECT | $4.22 $4.53 | ▲ +7.35% | ▼ −0.07% | $4.17 (−1.18%) |
Mar 16, 2026 32w ago | S-3 | $4.50 $4.46 | ▼ −0.89% | ▼ −4.67% | $4.17 (−7.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers